Stock Events

Stock Events

HUTCHMED (China) Limited 

$2.16
36
-$0.74-25.52% Tuesday 20:00

Statistics

Day High
3.82
Day Low
3.82
52W High
3.82
52W Low
2.16
Volume
468
Avg. Volume
2
Mkt Cap
375.44M
P/E Ratio
4.08
Dividend Yield
-
Dividend
-

Upcoming

Earnings

30JulExpected
Q3 2023
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Q2 2026
-0.11
0.1
0.31
0.52
Expected EPS
0.029
Actual EPS
0.02

Financials

83.3%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
548.51MRevenue
456.91MNet Income

Analyst Ratings

15.50Average Price Target
The highest estimate is 17.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
50%
Hold
50%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HMDCF. It's not an investment recommendation.
Microsoft
5
MSFT
Realty Income
5
O
Coca-Cola
5
KO
Altria Group
5
MO

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Zai Lab Limited
ZLAB
Mkt Cap2.93B
Zai Lab Limited is a biopharmaceutical company focused on discovering, developing, and commercializing innovative medicines in oncology and autoimmune disorders, directly competing with HUTCHMED's therapeutic areas.
Kura Oncology
KURA
Mkt Cap1.13B
Kura Oncology, Inc. is focused on the research and development of medications aimed at the treatment of cancer, directly competing with HUTCHMED's oncology focus.
Novartis
NVS
Mkt Cap292.35B
Novartis AG is a large pharmaceutical company with a strong presence in oncology, competing on a global scale with HUTCHMED in the cancer treatment market.
Pfizer
PFE
Mkt Cap159.36B
Pfizer Inc. is a global pharmaceutical corporation with a broad portfolio that includes oncology treatments, competing with HUTCHMED in the development and commercialization of cancer therapies.

About

HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.
Show more...
CEO
Chig Fung Cheng
Employees
1796
Country
Cayman Islands
ISIN
KYG4672N1198
WKN
000A2PJ5B

Listings

STU
DE
H7T2.STU
STU
DE
H7T1.STU
LSE
GB
0J7G.LSE
MU
DE
H7T2.MU

0 Comments

Share your thoughts

FAQ

What is HUTCHMED (China) Limited stock price today?▼
The current price of HMDCF is $2.16 USD — it has decreased by -25.52% in the past 24 hours. Watch HUTCHMED (China) Limited stock price performance more closely on the chart.
What is HUTCHMED (China) Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange HUTCHMED (China) Limited stocks are traded under the ticker HMDCF.
What is HUTCHMED (China) Limited market cap?▼
Today HUTCHMED (China) Limited has the market capitalization of 375.44M
When is the next HUTCHMED (China) Limited earnings date?▼
HUTCHMED (China) Limited is going to release the next earnings report on March 04, 2027.
What were HUTCHMED (China) Limited earnings last quarter?▼
HMDCF earnings for the last quarter are 0.02 USD per share, whereas the estimation was 0.03 USD resulting in a -31.03% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is HUTCHMED (China) Limited revenue for the last year?▼
HUTCHMED (China) Limited revenue for the last year amounts to 548.51M USD.
What is HUTCHMED (China) Limited net income for the last year?▼
HMDCF net income for the last year is 456.91M USD.
How many employees does HUTCHMED (China) Limited have?▼
As of September 03, 2026, the company has 1,796 employees.
In which sector is HUTCHMED (China) Limited located?▼
HUTCHMED (China) Limited operates in the Health & Wellness sector.
When did HUTCHMED (China) Limited complete a stock split?▼
The last stock split for HUTCHMED (China) Limited was on April 20, 2009 with a ratio of 1:50.
Where is HUTCHMED (China) Limited headquartered?▼
HUTCHMED (China) Limited is headquartered in Hong Kong, Cayman Islands.